A PHASE I, SINGLE-BLIND, RANDOMIZED STUDY OF THE SAFETY AND EFFICACY OF CELLULARIZED INTEGRA® USING AUTOLOGOUS BURN-DERIVED STEM CELLS.

Registry ID

142-2015

Source registry

HEALTH_CANADA

Status

Pending

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

HAMILTON HEALTH SCIENCES CORPORATION

Last update

2020-05-20

Conditions

• BURN

Related clinical trials

• THE EFFECTS OF METFORMIN ON AGING BIOMARKERS, MORBIDITY AND MORTALITY IN BURN PATIENTS - A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL (RCT)
• SASS 2: RECONSTITUTED BILAMELLAR AUTOLOGOUS SKIN FOR PERMANENET COVERING OF ACUTE PHASE CUTANEOUS WOUNDS ON MAJOR BURN VICTIMS
• ONCE DAILY AMINOGLYCOSIDE PHARMACOKINETICS AND OPTIMAL DOSING IN THE BURN POPULATION: A PROSPECTIVE STUDY

View on source registry